Rigel Pharmaceuticals
RIGL
#6719
Rank
$0.48 B
Marketcap
$27.41
Share price
0.70%
Change (1 day)
242.63%
Change (1 year)

Rigel Pharmaceuticals (RIGL) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : $0.15 Billion USD

According to Rigel Pharmaceuticals's latest financial reports the company's total liabilities are $0.15 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Rigel Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$0.14 B-1.37%
2022-12-31$0.14 B7.99%
2021-12-31$0.13 B79.37%
2020-12-31$76.35 M-18.56%
2019-12-31$93.75 M220.72%
2018-12-31$29.23 M58.31%
2017-12-31$18.46 M-20.09%
2016-12-31$23.1 M-42.76%
2015-12-31$40.36 M55.92%
2014-12-31$25.88 M45.39%
2013-12-31$17.8 M-14.99%
2012-12-31$20.94 M-0.05%
2011-12-31$20.95 M1.91%
2010-12-31$20.56 M-33.4%
2009-12-31$30.87 M-22.21%
2008-12-31$39.69 M18.11%
2007-12-31$33.6 M29.2%
2006-12-31$26.01 M-33.44%
2005-12-31$39.08 M47.35%
2004-12-31$26.52 M70.54%
2003-12-31$15.55 M-17.72%
2002-12-31$18.9 M7.96%
2001-12-31$17.5 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$69.32 M-56.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$64.74 B 40,792.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
$83.35 B 52,549.66%๐Ÿ‡บ๐Ÿ‡ธ USA